CD8a (Ly2, T cell Co-receptor, Leu2, T8) (PE)

Cat# C2259-29R-100ug

Size : 100ug

Brand : US Biological

Request more information



C2259-29R CD8a (Ly2, T cell Co-receptor, Leu2, T8) (PE)

Clone Type
Polyclonal
Host
mouse
Source
porcine
Isotype
IgG2a,k
Grade
Purified
Applications
FC IP
Crossreactivity
Po
Shipping Temp
Blue Ice
Storage Temp
4°C Do not freeze

Porcine CD8, a type I transmembrane glycoprotein, is expressed as either a CD8alpha/alpha homodimer or a CD8alpha/beta heterodimer. It is found on most thymocytes, and on the “suppressor/cytotoxic” subpopulation of peripheral T cells. CD8 functions primarily as a co-receptor with MHC Class I-restricted T-cell receptors in antigen recognition.||Applications:|Suitable for use in Flow Cytometry, Immunoprecipitation and Cytotoxicity assays. Other applications not tested.||Recommended Dilution:|Flow Cytometry: ≤ 0.2ug/10e6 cells.|Optimal dilutions to be determined by the researcher.||Storage and Stability:|May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for at least 12 months at 4°C. Freezing R-Phycoerythrin (PE) conjugates will result in a substantial loss of activity. PE conjugates are sensitive to light.

Applications
Product Type: Mab|Isotype: IgG2a,k|Clone No: 5K107 (76-2-11)|Host: mouse|Source: porcine|Concentration: ~0.1mg/ml|Form: Supplied as a liquid in PBS, 0.09% sodium azide and a stabilizing agent. Labeled with R-Phycoerythrin (PE). |Purity: Purified|Immunogen: Porcine CD8a|Specificity: Recognizes porcine CD8a, Mr 32-34kD. Reacts with the CD8 alpha chain.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
Porcine CD8a
Form
Supplied as a liquid in PBS, 0.09% sodium azide and a stabilizing agent. Labeled with R-Phycoerythrin (PE).
Purity
Purified
Specificity
Recognizes porcine CD8a, Mr 32-34kD. Reacts with the CD8 alpha chain.
References
1. Pescovitz, M.D, Lunney, K. and Sachs, D.H., J. Immunol. 133: 368 (1984). 2. Yamada, K., Sachs, D.H. and DerSimonian, H., J. Immunol. 155: 5249 (1995). 3. Smith, C.V., Sablinski, T., Arn, J.S., et al., J. Immunother. with Emphasis on Tumor Immunology 16: 105 (1994).